Cargando…
Blood transcript analysis and metastatic recurrent small bowel carcinoid management
BACKGROUND: Detection of neuroendocrine tumor (NET) disease progression is a key issue in determining management. Currently, assessment is by imaging (MRI/CT and Octreoscan®) and plasma Chromogranin A (CgA) measurement. CASE PRESENTATION: We report use of a NET-specific multigene PCR-derived blood t...
Autores principales: | Modlin, Irvin M, Drozdov, Ignat, Bodei, Lisa, Kidd, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4148943/ https://www.ncbi.nlm.nih.gov/pubmed/25095873 http://dx.doi.org/10.1186/1471-2407-14-564 |
Ejemplares similares
-
A PCR blood test outperforms chromogranin A in carcinoid detection and is unaffected by proton pump inhibitors
por: Modlin, Irvin M, et al.
Publicado: (2014) -
A liquid biopsy for bronchopulmonary/lung carcinoid diagnosis
por: Kidd, Mark, et al.
Publicado: (2017) -
Decoding the Molecular and Mutational Ambiguities of Gastroenteropancreatic Neuroendocrine Neoplasm Pathobiology
por: Kidd, Mark, et al.
Publicado: (2015) -
The Identification of Gut Neuroendocrine Tumor Disease by Multiple Synchronous Transcript Analysis in Blood
por: Modlin, Irvin M., et al.
Publicado: (2013) -
Gene network-based analysis identifies two potential subtypes of small intestinal neuroendocrine tumors
por: Kidd, Mark, et al.
Publicado: (2014)